Algo version: 0.98b
Vifor Pharma AG is listed at the OTC Exchange
Vifor Pharma AG [GNHAY]
OTC Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Vifor Pharma AG stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Vifor Pharma AG pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Thursday 12th of May 2022 were paid $0.411 per share. Over the last 6 times between 2016 and 2022, Vifor Pharma AG has paid $2.43985 with an average of $0.41 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Vifor Pharma AG 10 years ago, but if you had invested on Monday 7th of March 2022 when the price was $31.18, you would have made a profit of $7.21 per share or 23.11%

No, the average daily trading liquidity for Vifor Pharma AG is $13 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Vifor Pharma AG has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.90, the company's ability to pay off the debt is good. Vifor Pharma AG has a good net profit margin of 14.55% and should have high tolerances against inflation.

We have calculated the inflation risk for Vifor Pharma AG to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.